TITLE

CAN-FITE BIOPHARMA INITIATES CF102 TRIAL FOR LIVER CANCER

PUB. DATE
May 2009
SOURCE
Worldwide Biotech;May2009, Vol. 21 Issue 5, p8
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
This article reports on the plan of Can-Fite BioPharma of Israel to conduct a I/II clinical trial with CF102 for the treatment of liver cancer in 2009. Can-Fite announced that it will start enrolling patients for the clinical trial. The company will investigate the safety and efficacy of CF102 in patients with liver cancer.
ACCESSION #
38216166

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics